Variability in nucleotide excision repair and cancer risk: A review

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 149-158

  Benhamou, Simone ^a   Sarasin, Alain ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

Author keywords

Cancer susceptibility; Chemical carcinogens; DNA repair; Epidemiology; UV light

Indexed keywords

CARCINOGEN; ENVIRONMENTAL MUTAGEN; MUTAGENIC AGENT; NUCLEOTIDE;

BASAL CELL CARCINOMA; CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CARCINOMA; SMOKING; XERODERMA PIGMENTOSUM;

EID: 0034113806     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00032-6     Document Type: Article

References (33)

1. Stary A., Sarasin A. The genetic basis of xeroderma pigmentosum and trichothiodystrophy syndromes. Cancer Surveys. 26:1996;155-171.
2. Vermeulen W., Van Vuuren A.J., Chipoulet M., Schaeffer L., Appeldoor E., Weeda G., Jaspers N.G.J., Priestley A., Arlett C.F., Lehmann A.R., Stefanini M., Mezzina M., Sarasin A., Bootsma D., Egly J.M., Hoeijmakers J.H.J. Three unusual repair deficiencies associated with transcription factor BTF2 (TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harbor Symp. Quant. Biol. 59:1994;317-329.
3. Kraemer K.H., Lee M.M., Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol. 123:1987;241-250.
4. Sugasawa K., Ng J.M.Y., Masutani C., Iwai S., van der Spek P.J., Eker A.P.M., Hanaoka F., Bootsma D., Hoeijmakers J.H.J. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell. 2:1998;223-232.
5. Venema J., Mullenders L.H.F., Natarajan A.T., van Zeeland A.A., Mayne L.V. The genetic defect in Cockayne's syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc. Natl. Acad. Sci. U.S.A. 87:1990;4707-4711.
6. Schaeffer L., Moncollin V., Roy R., Staub A., Mezzina M., Sarasin A., Weeda G., Hoeijmakers J.H.J., Egly J.M. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 13:1994;2388-2392.
7. Aboussekhra A., Biggerstaf M., Shivji M.K.K., Vilpo J.A., Moncollin V., Podust V.N., protic M., Hübscher U., Egly J.-M., Wood R.D. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell. 80:1995;859-868.
8. Sarasin A., Blanchet-Bardon C., Renault G., Lehmann A., Arlett C., Dumez Y. Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair. Br. J. Dermatol. 127:1992;485-491.
9. Athas W.F., Hedayati M., Matanoski G.M., Farmer E.R., Grossman L. Development and field test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res. 51:1991;5786-5793.
10. Carreau M., Eveno E., Quilliet X., Chevallier-Lagente O., Benoit A., Tanganelli B., Stefanini M., Vermeulen W., Hoeijmakers J.H.J., Sarasin A., Mezzina M. Development of a new and easy complementation assay for DNA repair-deficient human syndromes using cloned repair genes. Carcinogenesis. 16:1995;1003-1009.
11. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiologic study. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1614-1618.
12. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
13. Alapetite C., Benoit A., Moustacchi E., Sarasin A. The comet assay, as a repair test for prenatal diagnosis of xeroderma pigmentosum and trichothiodystrophy. J. Invest. Dermatol. 108:1997;154-159.
14. Leprat F., Alapetite C., Rosselli F., Ridet A., Schlumberger M., Sarasin A., Suarez H.G., Moustacchi E. Impaired DNA repair as assessed by the "comet" assay in patients with thyroid tumors after a history of radiation therapy: a preliminary study. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;1019-1026.
15. Wei Q., Spitz M.R., Gu J., Cheng L., Xu X., Strom S.S., Kripke M.L., Hsu T.C. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol. Biomarkers Prev. 5:1996;199-204.
16. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res. 54:1994;437-440.
17. Grossman L. Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ. Health Perspect. 105:1997;927-930.
18. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J. Invest. Dermatol. 104:1995;933-936.
19. Hall J., English D.R., Artuso M., Armstrong B.K., Winter M. DNA repair capacity as a risk factor for non-melanocytic skin cancer - a molecular epidemiological study. Int. J. Cancer. 58:1994;179-184.
20. Dybdahl M., Frentz G., Vogel U., Wallin H., Nexo B.A. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutat. Res. 433:1999;15-22.
21. Wei Q., Cheng L., Hong W.K., Spitz M.R. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 56:1996;4103-4107.
22. Cheng L., Eicher S.A., Guo Z., Hong W.K., Spitz M.R., Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev. 7:1998;465-468.
23. Wei Q., Gu J., Cheng L., Bondy M.L., Jiang H., Hong W.K., Spitz M.R. Benzo(a)pyrene diol expoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 56:1996;3975-3979.
24. Wu X., Gu J., Amos C.I., Jiang H., Hong W.K., Spitz M.R. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer. 83:1998;1118-1127.
25. Wang L.-E., Sturgis E.M., Eicher S.A., Spitz M.R., Hong W.K., Wei Q. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin. Cancer Res. 4:1998;1773-1778.
26. Wu X., Gu J., Hong W.K., Lee J.J., Amos C.I., Jiang H., Winn R.J., King-Wah Fu K., Cooper J., Spitz M.R. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J. Natl. Cancer Inst. 90:1998;1393-1399.
27. Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int. J. Cancer. 71:1997;1-3.
28. Shen M.R., Jones I.M., Mohrenweiser H. Non-conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:1998;604-608.
29. Wu X., Amos C.I., Wang M., Hong W.K., Mohrenweiser H.W., Spitz M.R. Association of a polymorphism in exon 23 of the DNA repair gene, XPD, and lung cancer risk. Proc. Am. Assoc. Cancer Res. 40:1999;89.
30. Escobar P., Modugno F., Kanbour-Shakir A., Naus G., Mohrenweiser H., Romkes M. Analysis of the DNA repair enzyme XDP exon 23 polymorphism and cancer risk. Proc. Am. Assoc. Cancer Res. 40:1999;213.
31. Dybdahl M., Vogel U., Frentz G., Wallin H., Nexo B.A. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 8:1999;77-81.
32. Moller P., Dybdahl M., Wallin H., Vogel U., Frentz G., Nexo B. Skin cancer patients have different DNA repair activity in lymphocytes, evidenced by more DNA strand breaks after UVC radiation, and more frequently A alleles at two polymorphic sites in the XPD gene. Pharmacol. Toxicol. 85(1):1999;30-31. Suppl.
33. Dumaz N., Duthu A., Ehrhart J.C., Drougard C., Appella E., Anderson C.W., Sarasin A., Daya-Grosjean L. Prolonged p53 accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strand of cellular genes. Mol. Carcinogen. 20:1997;340-347.